Deleuran, M.; Marcoux, D.; De Bruin-Weller, M. S.; Irvine, A. D.; Baselga, E.; Ahn, K.; Castro, A. P.; Bansal, A.; Chao, J.; Bégo-Le-Bagousse, G. Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents With Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use. Acta Derm Venereol 2021, 101, adv00504.